Finerenone for Patients With CKD and Type 2 Diabetes
Finerenone reduced the risks of chronic kidney disease (CKD) progression and cardiovascular events among patients with CKD and type 2 diabetes in an international phase 3 trial.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Heart | Urology & Nephrology